Amgen (AMGN)
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-07-08
$367.99-0.03%
Close 2026-07-08 · 1-day change
Reading AMGN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AMGN free→NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-07-08
Reading AMGN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AMGN free→QuarterlyIQ Insights · AMGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 37,220.0 | 36,751.0 | 33,424.0 | 28,190.0 | 26,323.0 | 25,979.0 | 25,424.0 | 23,362.0 | 22,991.0 | 22,991.0 | 22,991.0 | 21,662.0 | 17,265.0 | 17,265.0 | 17,265.0 | 15,582.0 | 15,003.0 | 15,003.0 |
| Total Revenues | — | — | — | — | — | — | 25,424.0 | 23,362.0 | 22,991.0 | 22,991.0 | 22,991.0 | 21,662.0 | 17,265.0 | 17,265.0 | 17,265.0 | 15,582.0 | 15,003.0 | 15,003.0 |
| Cost of Revenues | 11,813.0 | 12,037.0 | 12,858.0 | 8,451.0 | 6,406.0 | 6,454.0 | 6,159.0 | 4,356.0 | 4,162.0 | — | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | 4,628.0 | 4,905.0 | 4,510.0 | 4,596.0 | 4,258.0 | 3,991.0 | 3,770.0 | 3,485.0 | 3,251.0 | 3,188.0 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 6,965.0 | 7,050.0 | 7,096.0 | 6,179.0 | 5,414.0 | 5,368.0 | 5,730.0 | 5,150.0 | 5,062.0 | 5,062.0 | 5,062.0 | 4,846.0 | 4,814.0 | 4,814.0 | 4,801.0 | 4,486.0 | 3,789.0 | 3,789.0 |
| Operating Income | 10,568.0 | 9,080.0 | 7,258.0 | 7,897.0 | 9,566.0 | 7,639.0 | 9,139.0 | 9,674.0 | 9,794.0 | 9,794.0 | 9,794.0 | 8,470.0 | 5,577.0 | 5,577.0 | 5,577.0 | 4,312.0 | 5,214.0 | 5,214.0 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest & Investment Income | 383.0 | 408.0 | 510.0 | 1,200.0 | 127.0 | 11.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 1,208.0 | 2,651.0 | 506.0 | 2,833.0 | (814.0) | 259.0 | 256.0 | 753.0 | 629.0 | 629.0 | 629.0 | 603.0 | 485.0 | 485.0 | 485.0 | 448.0 | 352.0 | 352.0 |
| Asset Writedown | — | — | — | — | — | — | — | — | — | (111.0) | (111.0) | (111.0) | 87.0 | — | — | — | — | — |
| EBT, Incl. Unusual Items | 9,087.0 | 8,976.0 | 4,609.0 | 7,855.0 | 7,346.0 | 6,701.0 | 8,133.0 | 9,138.0 | 9,163.0 | 9,163.0 | 9,163.0 | 7,978.0 | 5,009.0 | 5,009.0 | 5,009.0 | 4,150.0 | 5,015.0 | 5,015.0 |
| Income Tax Expense | 1,287.0 | 1,265.0 | 519.0 | 1,138.0 | 794.0 | 808.0 | 869.0 | 1,296.0 | 1,441.0 | 1,441.0 | 1,441.0 | 1,039.0 | 664.0 | 664.0 | 664.0 | 467.0 | 963.0 | 963.0 |
| Net Income | ||||||||||||||||||
| Net Income | 7,800.0 | 7,711.0 | 4,090.0 | 6,717.0 | 6,552.0 | 5,893.0 | 7,264.0 | 7,842.0 | 7,722.0 | 7,722.0 | 7,722.0 | 6,939.0 | 4,345.0 | 4,345.0 | 4,345.0 | 3,683.0 | 4,052.0 | 4,052.0 |
| Per Share | ||||||||||||||||||
| Basic EPS | 14.44 | 14.33 | 7.62 | 12.56 | 12.18 | 10.34 | 12.40 | 12.96 | 10.32 | 10.32 | 10.32 | 9.15 | 5.61 | 5.61 | 5.61 | 4.07 | 3.79 | 3.79 |
| Diluted EPS | 14.34 | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 | 12.31 | 12.88 | 10.24 | 10.24 | 10.24 | 9.06 | 5.52 | 5.52 | 5.52 | 4.04 | 3.77 | 3.77 |
| Revenue per Share | 68.42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | 9.80 | 9.66 | 9.13 | 8.64 | 7.95 | 7.22 | 6.56 | 5.95 | 4.15 | 1.32 | — | — | — | 0.47 | 0.47 | 0.28 | — | — |
| Basic Weighted Avg Shares | 540.0 | 538.0 | 537.0 | 535.0 | 538.0 | 570.0 | 586.0 | 605.0 | 748.0 | 748.0 | 748.0 | 758.0 | 775.0 | 775.0 | 775.0 | 905.0 | 1,070.0 | 1,070.0 |
| Diluted Weighted Avg Shares | 544.0 | 542.0 | 541.0 | 538.0 | 541.0 | 573.0 | 590.0 | 609.0 | 754.0 | 754.0 | 754.0 | 766.0 | 787.0 | 787.0 | 787.0 | 912.0 | 1,075.0 | 1,075.0 |
| Payout Ratio | 68.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 9,967.0 | 8,063.0 | 8,721.0 | 10,384.0 | 11,037.0 | 12,740.0 | 11,880.0 | 11,899.0 | 11,899.0 | 11,899.0 | 10,578.0 | 6,665.0 | 6,665.0 | 6,665.0 | 5,372.0 | 6,287.0 | 6,287.0 |
| EBIT | 10,568.0 | 9,080.0 | 7,258.0 | 7,897.0 | 9,566.0 | 7,639.0 | 9,139.0 | 9,674.0 | 9,794.0 | 9,794.0 | 9,794.0 | 8,470.0 | 5,577.0 | 5,577.0 | 5,577.0 | 4,312.0 | 5,214.0 | 5,214.0 |
| Effective Tax Rate | 14.2% | 14.1% | 11.3% | 14.5% | 10.8% | 12.1% | 10.7% | 14.2% | 15.7% | 15.7% | 15.7% | 13.0% | 13.3% | 13.3% | 13.3% | 11.3% | 19.2% | 19.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.